Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Replimune (REPL) Common Equity (2018 - 2025)

Replimune has reported Common Equity over the past 8 years, most recently at $210.5 million for Q4 2025.

  • Quarterly results put Common Equity at $210.5 million for Q4 2025, down 56.35% from a year ago — trailing twelve months through Dec 2025 was $210.5 million (down 56.35% YoY), and the annual figure for FY2025 was $415.8 million, up 11.04%.
  • Common Equity reached $210.5 million in Q4 2025 per REPL's latest filing, down from $263.3 million in the prior quarter.
  • Across five years, Common Equity topped out at $595.3 million in Q4 2022 and bottomed at $210.5 million in Q4 2025.
  • Median Common Equity over the past 5 years was $424.0 million (2023), compared with a mean of $426.0 million.
  • The largest annual shift saw Common Equity soared 171.46% in 2021 before it tumbled 56.35% in 2025.
  • Over 5 years, Common Equity stood at $437.5 million in 2021, then skyrocketed by 36.08% to $595.3 million in 2022, then decreased by 29.19% to $421.5 million in 2023, then increased by 14.43% to $482.4 million in 2024, then crashed by 56.35% to $210.5 million in 2025.
  • Business Quant data shows Common Equity for REPL at $210.5 million in Q4 2025, $263.3 million in Q3 2025, and $336.7 million in Q2 2025.